Evonetix
Evonetix Inks Deal With Analog Devices to Expand Thermally Controlled Enzymatic DNA Synthesis
The companies have signed a joint development and a commercial supply agreement to develop a semiconductor-based gene synthesis benchtop platform.
Evonetix Raises $24M in Extended Series B Funding Round
The company has now raised over $54 million in total Series B funding and has launched an early-access program for its DNA synthesis technology.
Instead of using acid to deprotect nucleotides during enzymatic DNA synthesis, the UK startup’s approach removes the blocking groups thermally.
Evonetix Extends DNA Synthesis Partnership With Semiconductor Firm Analog Devices
The companies, which have been working since early 2019, will work together on Evonetix's first product, a desktop DNA synthesizer.
Evonetix Closes £23M Series B Financing
The Cambridge, UK-based gene synthesis firm plans to use the funds to accelerate development of its silicon platform and introduce a desktop device.
Oct 2, 2019
Jan 30, 2018